Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Waldenstrom Macroglobulinemia × Topotecan × 30 days × Clear all

Sponsor

Conditions

Small Cell Lung Carcinoma 5 Ovarian Neoplasms 3 Uterine Cervical Neoplasms 2 Neuroblastoma 2 Ganglioneuroblastoma 2 Wilms Tumor 1 Thrombocythemia, Essential 1 Sarcoma, Ewing 1 Rhabdoid Tumor 1 Primary Myelofibrosis 1 Polycythemia Vera 1 Pleuropulmonary blastoma 1 Myelodysplastic-Myeloproliferative Diseases 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1 Leukemia, Myeloid, Acute 1 Fallopian Tube Neoplasms 1

Interventions

ibrutinib 4 Rituximab 4 zanubrutinib 3 venetoclax 2 ixazomib 2 Prednisone 2 Cyclophosphamide 2 CT-P10 2 talquetamab 1 pirtobrutinib 1 fludarabine 1 brexucabtagene autoleucel 1 Vincristine 1 Valacyclovir 1 Specimen Handling 1 Sirolimus 1 Pharmacogenomic Variants 1 Magnetic Resonance Spectroscopy 1 Lenalidomide 1 Everolimus 1 Etoposide 1 Doxorubicin 1 Bortezomib 1 Biopsy 1 ARQ531 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡